Fund Holdings — Deep Track Capital, LP

Total Portfolio Value:
$5.94B
Total Bought:
$1.45B
Total Sold:
$1.53B
Net Transaction:
-$82.55M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Guardant Health, Inc.(GH)3,393,3122,805,677-587,635$509.10M$500.42M8.42%-$8.68M
BioMarin Pharmaceutical Inc.(BMRN)3,307,4816,374,395+3,066,914$189.25M$382.46M6.44%+$193.21M
Immunovant, Inc.(IMVT)9,341,1519,160,801-180,350$359.91M$309.45M5.21%-$50.46M
Tarsus Pharmaceuticals, Inc.(TARS)3,666,7683,806,768+140,000$230.79M$299.25M5.04%+$68.46M
Veradermics, Incorporated(MANE)2,000,0001,900,000-100,000$245.88M$230.34M3.88%-$15.54M
Vera Therapeutics, Inc.CL A(VERA)4,000,0007,000,000+3,000,000$171.64M$226.03M3.80%+$54.39M
Vaxcyte, Inc.(PCVX)4,300,0003,513,069-786,931$249.96M$199.89M3.36%-$50.07M
Alkermes plcSHS(ALKS)4,000,0004,500,000+500,000$209.58M$182.34M3.07%-$27.24M
Ocular Therapeutix, Inc.(OCUL)19,686,28221,939,625+2,253,343$193.32M$168.28M2.83%-$25.04M
United Therapeutics Corporation(UTHR)123,616300,040+176,424$66.98M$162.59M2.74%+$95.61M
Structure Therapeutics IncADS4,740,0725,000,000+259,928$254.40M$156.35M2.63%-$98.05M
GRAIL, Inc.(GRAL)1,834,9441,104,200-730,744$125.27M$154.72M2.60%+$29.45M
Insmed Incorporated(INSM)01,350,000+1,350,000$0$154.09M2.59%+$154.09M
COMPASS Pathways plcADS(CMPS)12,161,49612,161,4960$172.09M$151.29M2.55%-$20.80M
Genmab A/SADS(GMAB)5,650,0004,182,689-1,467,311$155.21M$149.22M2.51%-$5.99M
Axsome Therapeutics, Inc.(AXSM)700,000800,000+100,000$171.34M$147.51M2.48%-$23.83M
Nurix Therapeutics, Inc.(NRIX)7,736,4556,000,000-1,736,455$187.69M$142.26M2.39%-$45.43M
LB Pharmaceuticals Inc(LBRX)3,352,8043,352,8040$108.82M$128.68M2.17%+$19.87M
Tango Therapeutics, Inc.(TNGX)4,200,0004,500,000+300,000$131.29M$112.28M1.89%-$19.02M
Maze Therapeutics, Inc.(MAZE)3,732,5694,083,969+351,400$111.38M$111.00M1.87%-$377.6K
Hemab Therapeutics Hldgs Inc3,602,0933,587,796-14,297$132.30M$110.65M1.86%-$21.66M
MoonLake ImmunotherapeuticsCL A(MLTX)6,999,0258,105,290+1,106,265$136.27M$94.83M1.60%-$41.44M
Oruka Therapeutics, Inc.(ORKA)1,926,0001,069,774-856,226$183.30M$89.10M1.50%-$94.20M
GeneDx Holdings Corp.CL A(WGS)700,0001,200,000+500,000$48.05M$86.76M1.46%+$38.70M
Cogent Biosciences, Inc.(COGT)2,000,0002,500,000+500,000$77.40M$80.05M1.35%+$2.65M
GH Research PLC(GHRS)3,333,3343,333,3340$89.60M$78.27M1.32%-$11.33M
Bicara Therapeutics Inc4,100,0004,100,0000$121.73M$76.30M1.28%-$45.43M
Latigo Biotherapeutics Inc04,408,322+4,408,322$0$73.62M1.24%+$73.62M
Celldex Therapeutics, Inc.(CLDX)2,939,1512,125,532-813,619$109.37M$68.89M1.16%-$40.48M
BridgeBio Pharma, Inc.(BBIO)0885,882+885,882$0$58.29M0.98%+$58.29M
Avalo Therapeutics Inc3,610,0003,610,0000$66.71M$55.34M0.93%-$11.37M
Alumis Inc6,348,5587,469,746+1,121,188$178.65M$55.20M0.93%-$123.45M
Altimmune Inc19,250,00019,250,0000$58.52M$55.05M0.93%-$3.46M
Attovia Therapeutics Inc03,207,138+3,207,138$0$54.97M0.93%+$54.97M
Billiontoone IncCL A0500,000+500,000$0$53.22M0.90%+$53.22M
Aclaris Therapeutics Inc9,345,0009,345,0000$49.44M$49.15M0.83%-$280.4K
Cormedix Inc6,274,0766,274,0760$49.25M$48.31M0.81%-$941.1K
Edgewise Therapeutics, Inc.(EWTX)01,148,817+1,148,817$0$46.64M0.78%+$46.64M
Verastem, Inc.(VSTM)5,740,8505,740,8500$21.93M$46.21M0.78%+$24.28M
Definium Therapeutics, Inc.(DFTX)2,750,0001,000,000-1,750,000$129.36M$38.06M0.64%-$91.30M
Generate Biomedicines, Inc.(GENB)1,333,8152,507,449+1,173,634$22.50M$37.66M0.63%+$15.16M
MBX Biosciences, Inc.(MBX)1,732,569640,000-1,092,569$95.64M$37.52M0.63%-$58.12M
ANI Pharmaceuticals, Inc.(ANIP)0500,000+500,000$0$36.33M0.61%+$36.33M
Viridian Therapeutics, Inc.(VRDN)3,592,7401,711,030-1,881,710$66.00M$35.23M0.59%-$30.77M
Harrow, Inc.(HROW)969,0001,069,000+100,000$41.15M$32.93M0.55%-$8.23M
Obsidian Therapeutics Inc02,120,050+2,120,050$0$29.11M0.49%+$29.11M
Corvus Pharmaceuticals, Inc.(CRVS)2,491,9392,491,9390$37.23M$28.71M0.48%-$8.52M
Neurocrine Biosciences, Inc.(NBIX)0200,000+200,000$0$28.37M0.48%+$28.37M
Solid Biosciences Inc3,565,0623,565,0620$35.61M$25.78M0.43%-$9.84M
Shattuck Labs Inc3,706,7343,706,7340$25.72M$25.28M0.43%-$444.8K
Beam Therapeutics Inc.(BEAM)1,000,0001,000,0000$34.32M$24.45M0.41%-$9.87M
MannKind Corporation(MNKD)6,000,0005,030,522-969,478$25.56M$19.62M0.33%-$5.94M
Xenon Pharmaceuticals Inc.(XENE)0500,000+500,000$0$18.59M0.31%+$18.59M
Olema Pharmaceuticals Inc1,500,0002,109,951+609,951$18.77M$18.23M0.31%-$535.0K
Nektar Therapeutics(NKTR)300,000300,0000$20.94M$18.16M0.31%-$2.78M
Design Therapeutics Inc01,323,986+1,323,986$0$16.64M0.28%+$16.64M
Century Therapeutics Inc9,462,6459,462,6450$23.18M$16.18M0.27%-$7.00M
Xencor, Inc.(XNCR)593,551540,000-53,551$9.56M$13.47M0.23%+$3.92M
Maplight Therapeutics Inc01,318,101+1,318,101$0$13.43M0.23%+$13.43M
Enanta Pharmaceuticals Inc1,444,1671,000,000-444,167$21.06M$13.18M0.22%-$7.88M
X4 Pharmaceuticals Inc5,878,7574,501,684-1,377,073$27.45M$13.05M0.22%-$14.40M
Kardigan Inc600,000600,0000$14.31M$8.85M0.15%-$5.46M
Promis Neurosciences Inc835,655740,117-95,538$11.00M$8.03M0.14%-$2.97M
Entera Bio LtdSHS02,450,980+2,450,980$0$7.13M0.12%+$7.13M
Rxsight Inc01,230,566+1,230,566$0$6.03M0.10%+$6.03M
Rainier Acquisition CorpUNIT 08 24 20310500,000+500,000$0$5.10M0.09%+$5.10M
Jatt Iii Acquisition Corp0450,000+450,000$0$4.96M0.08%+$4.96M
Research Alliance Corp IvCL A0400,000+400,000$0$4.63M0.08%+$4.63M
Tcgx Acquisition CorpCL A0300,000+300,000$0$3.75M0.06%+$3.75M
Aligos Therapeutics Inc444,110444,1100$2.56M$2.50M0.04%-$62.2K
Context Therapeutics Inc7,419,3557,419,3550$4.11M$2.23M0.04%-$1.88M
Alnylam Pharmaceuticals, Inc.(ALNY)825,0000-825,000$248.35M$0—-$248.35M
Ataibeckley Inc14,417,4420-14,417,442$75.98M$0—-$75.98M
Cytokinetics, Incorporated(CYTK)700,0000-700,000$59.63M$0—-$59.63M
Dyne Therapeutics, Inc.(DYN)1,500,0000-1,500,000$33.31M$0—-$33.31M
Enliven Therapeutics Inc225,0000-225,000$11.42M$0—-$11.42M
Immix Biopharma, Inc.(IMMX)2,775,0000-2,775,000$28.61M$0—-$28.61M
Immunocore Holdings plcADS(IMCR)311,2180-311,218$9.88M$0—-$9.88M
Inventiva S.A.ADS(IVA)800,0000-800,000$3.02M$0—-$3.02M
Ionis Pharmaceuticals, Inc.(IONS)2,200,0000-2,200,000$174.44M$0—-$174.44M
Kailera Therapeutics Inc700,0000-700,000$15.42M$0—-$15.42M
Kura Oncology, Inc.(KURA)1,978,5650-1,978,565$21.70M$0—-$21.70M
Nuvalent Inc1,783,3220-1,783,322$220.24M$0—-$220.24M
Personalis, Inc.(PSNL)4,000,0000-4,000,000$53.60M$0—-$53.60M
Page 1 of 1
Deep Track Capital, LP — 13F Holdings — Q3 2026 | TickerTrail